Stock comparison
WATERS CORP /DE/ is 6.1x more valuable than 10x Genomics, Inc. by market capitalization ($45.30 B vs $7.46 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
WAT is larger
WATERS CORP /DE/ is 6.1x more valuable than 10x Genomics, Inc. by market capitalization ($45.30 B vs $7.46 B).
Market value leader
WAT
WATERS CORP /DE/ is 6.1x more valuable than 10x Genomics, Inc. by market capitalization ($45.30 B vs $7.46 B).
Revenue leader
WAT
TXG: $642.82M vs WAT: $3.17B.
Profit leader
WAT
TXG: -$43.50M vs WAT: $642.63M.
Margin leader
WAT
TXG: -6.8% vs WAT: 20.3% net margin.
| Metric | TXG | WAT |
|---|---|---|
| Market cap | $7.46 B | $45.30 B |
| US-listed rank | #1092 | #346 |
| Revenue (latest FY) | $642.82M | $3.17B |
| Net income (latest FY) | -$43.50M | $642.63M |
| Net margin | -6.8% | 20.3% |
| P/E (trailing FY) | - | 70.5x |
| SEC filings | 652 | 1,887 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
WATERS CORP /DE/ is 6.1x more valuable than 10x Genomics, Inc. by market capitalization ($45.30 B vs $7.46 B).
In their latest fiscal years, 10x Genomics, Inc. reported $642.82M in revenue while WATERS CORP /DE/ reported $3.17B.
Full pages: 10x Genomics, Inc. and WATERS CORP /DE/, or browse the full rankings.